학술논문
Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial
Document Type
Article
Author
Wedemeyer, Heiner ; Yurdaydin, Cihan ; Hardtke, Svenja; Caruntu, Florin Alexandru; Curescu, Manuela G; Yalcin, Kendal; Akarca, Ulus S; Gürel, Selim; Zeuzem, Stefan; Erhardt, Andreas; Lüth, Stefan; Papatheodoridis, George V; Keskin, Onur; Port, Kerstin; Radu, Monica; Celen, Mustafa K; Idilman, Ramazan; Weber, Kristina; Stift, Judith; Wittkop, Ulrike; Heidrich, Benjamin; Mederacke, Ingmar; von der Leyen, Heiko; Dienes, Hans Peter; Cornberg, Markus; Koch, Armin; Manns, Michael P
Source
In The Lancet Infectious Diseases March 2019 19(3):275-286
Subject
Language
ISSN
1473-3099